Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229–63.

Article  Google Scholar 

Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247–69.

Article  CAS  PubMed  Google Scholar 

Lin NU, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the national comprehensive cancer network. Cancer. 2012;118(22):5463–72.

Article  PubMed  Google Scholar 

Waks AG, Winer EP. Breast cancer treatment.  Rev JAMA. 2019;321(3):288–300.

Article  CAS  Google Scholar 

Schmid P, et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N Engl J Med. 2018;379(22):2108–21.

Article  CAS  PubMed  Google Scholar 

Denkert C, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40–50.

Article  PubMed  Google Scholar 

Fehrenbacher L, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet (London England). 2016;387(10030):1837–46.

Article  CAS  PubMed  Google Scholar 

Loi S, et al. Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers. J Clin Oncol Off J Am Soc Clin Oncol. 2019;37(7):559–69.

Article  Google Scholar 

Topalian SL, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luen S, et al. The genomic landscape of breast cancer and its interaction with host immunity. Breast (Edinburgh Scotland). 2016;29:241–50.

Article  PubMed  Google Scholar 

Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015. 348(6230): 69–74. 

Diseases GBDaI. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet (London, England). 2020;396(10258):1204–22.

Article  Google Scholar 

Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(1):55–68.

Article  CAS  PubMed  Google Scholar 

Benros ME, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70(8):812–20.

Article  PubMed  Google Scholar 

Bortolato B, et al. Depression in cancer: the many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2017;52:58–70.

Article  PubMed  Google Scholar 

Windle M, Windle RC. Recurrent depression, cardiovascular disease, and diabetes among middle-aged and older adult women. J Affect Disord. 2013;150(3):895–902.

Article  PubMed  PubMed Central  Google Scholar 

Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialog Clin Neurosci, 2011. 13(1).

Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzales EL, et al. Correlation between immune-related genes and depression-like features in an animal model and in humans. Behav Immun. 2023;113:29–43. Brain.

Article  CAS  Google Scholar 

Anuk D, et al. The characteristics and risk factors for common psychiatric disorders in patients with cancer seeking help for mental health. BMC Psychiatry. 2019;19(1):269.

Article  PubMed  PubMed Central  Google Scholar 

Maass SWMC et al. Long-term psychological distress in breast cancer survivors and their matched controls: a cross-sectional study. Maturitas. 2019. 10.1016/j.maturitas.2019.09.003

Li L, et al. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol. 2020;88:106939.

Article  CAS  PubMed  Google Scholar 

Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815.

Article  PubMed  PubMed Central  Google Scholar 

Berraondo P, et al. Innate immune mediators in cancer: between defense and resistance. Immunol Rev. 2016;274(1):290–306.

Article  CAS  PubMed  Google Scholar 

Han TJ, et al. Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy. Psycho-oncology. 2016;25(2):187–93.

Article  PubMed  Google Scholar 

Mundy-Bosse BL, et al. Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cell Immunol. 2011;270(1):80–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura K, Smyth MJ. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol, 2020. 17(1).

Renzi C, et al. Stress exposure in significant relationships is associated with lymph node status in breast cancer. PLoS ONE. 2016;11(2):e0149443.

Article  PubMed  PubMed Central  Google Scholar 

Man YG, et al. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. J Cancer. 2013;4(1):84–95.

Article  PubMed  PubMed Central  Google Scholar 

Castro-Figueroa EM, et al. Depression, anxiety, and social environmental adversity as potential modulators of the immune tumor microenvironment in breast cancer patients.  Med Sci. 2021; 9: 2.

Nagy C, et al. Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons. Nat Neurosci. 2020;23(6):771–81.

Article  CAS  PubMed  Google Scholar 

Jézéquel P, et al. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Res BCR. 2015;17:43.

Article  PubMed  Google Scholar 

Szklarczyk D, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucl Acid Res. 2021;49(D1):D605-12.

Article  CAS  Google Scholar 

Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

The Gene Ontology Consortium. The gene ontology resource: 20 years and still GOing strong. Nucl Acid Res. 2019. 47(D1): D330–8.

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucl Acid Res. 2000;28(1):27–30.

Article  CAS  Google Scholar 

Xu Q, et al. Landscape of immune microenvironment under immune cell infiltration pattern in breast cancer. Front Immunol. 2021;12:711433.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9):e107468.

Article  PubMed  PubMed Central  Google Scholar 

Mitchell AJ, et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lan